this is why it's a long hold

, a NASDAQ-listed international medical cannabis company, has decided to halt equity financing for a 30-day period while exploring strategic investment opportunities in the global cannabis and technology markets. The company has recently completed public offerings amounting to nearly $6 million and sold its subsidiary, RPK, resulting in a $4 million debt reduction and over $1.5 million in net cash. Interim CEO Katie Field emphasizes a cautious approach to investing, aiming to strengthen Akanda’s cash position without increasing the company’s expenditure rate. This has big potential. here is just one other weed stock. I honestly couldn't think of the other 2 I had in mind when writing this.. All I'm getting at is it's down for strategic reasons.